Precision Medicine News and Research

RSS

Beyond ‘bad’ cholesterol: new clues to the risk of heart disease

Researchers at Chalmers University of Technology, in Sweden, shed new light on the remaining risk of heart disease, even after the known risk factor of ‘bad’ cholesterol is brought down to a healthy level.

13 Oct 2026

Mursla Bio publishes peer-reviewed validation of tissue-specific extracellular vesicle platform for liquid biopsy

Mursla Bio, a precision medicine and diagnostics company built on tissue-specific extracellular vesicles (TS-EVs), today announced publication of a peer-reviewed study in the Journal of Extracellular Vesicles (impact factor 21.7), the founding journal of the International Society for Extracellular Vesicles. This validates the TS-EV platform for a new class of liquid biopsy: the multiomic disease biology of living cells in a chosen tissue, read from blood, starting with the liver.

From Mursla Bio 13 Oct 2026

New review highlights expanding potential of therapeutic DNA vaccines

A new review published in Genes & Diseases highlights the expanding potential of DNA-based vaccines as a flexible platform for preventing infectious diseases, treating cancer and strengthening preparedness for future disease outbreaks.

12 Oct 2026

Study identifies a link between specific brain circuits and anxiety in adolescents

Adolescence is a sensitive period for brain development and mental health, though the connection between the two is not fully understood.

9 Oct 2026

DNA Typewriter tracks cell divisions and developmental decisions in mice

Scientists have succeeded in reconstructing the family tree of cells in a developing mouse embryo. They recorded cells' relationships, starting when the fertilized egg first split in two and ending after the body with organs took shape.

8 Oct 2026

Precise phenotyping improves genetic prediction of sensorineural hearing loss

A team of hearing specialists at Vanderbilt Health analyzed thousands of data samples in the institution’s BioVU biobank to understand genetic susceptibility of sensorineural hearing loss, which is caused by damage to the inner ear.

8 Oct 2026

ELRIG and The Protein Society announce keynote speakers for Protein Sciences in Drug Discovery 2026

ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community, and The Protein Society, an international, not-for-profit, scholarly society, with the mission to provide forums for the advancement of research into protein structure, function, design and applications, today announced the keynote speakers for Protein Sciences in Drug Discovery 2026.

From ELRIG (UK) Ltd. 8 Oct 2026

C-Path and University of Arizona collaborate to investigate cellular mechanisms of Parkinson's disease in women

Critical Path Institute (C-Path) today announced a research collaboration with the University of Arizona to investigate the cellular mechanisms that drive Parkinson's disease in women.

6 Oct 2026

Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer

Alliance Foundation Trials, LLC (AFT), a national leader in conducting innovative, practice-changing cancer clinical trials, and Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the launch of AFT-70 NAVIGATE, a randomized phase III trial evaluating a novel molecular residual disease (MRD)-guided treatment strategy for patients with intermediate and high-risk ER-positive/HER2-negative early breast cancer.

5 Oct 2026

New model predicts growth hormone therapy response in children with short stature

Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for their age and sex without any identifiable medical cause.

5 Oct 2026

Varying mutation rates in healthy organs explain cancer risk

A new study by scientists at City of Hope® and TGen, part of City of Hope, found surprisingly large differences in the number of mutations present in organs of healthy individuals.

1 Oct 2026

Common gene variant reduces effectiveness of pediatric asthma drug

Children with a variant in the SERPINE1 gene – which is found in 60% of the population – may be less responsive to mepolizumab, a drug used to treat asthma flares, according to a study published in the Journal of Allergy and Clinical Immunology.

1 Oct 2026

Esophageal cancer leaves a distinct metabolic signature in the gut

The study uncovers gut microbial and metabolic signatures in esophageal cancer, emphasizing lipid dysregulation and its potential role in disease progression.

1 Oct 2026

Label-free microfluidic chip and AI identify blood-borne tumor cells

Finding a few tumor cells hidden among billions of blood cells is one of the biggest challenges in liquid biopsy.

30 Sep 2026

Neck lymph node removal surgery may disrupt brain waste clearance

Surgery to remove lymph nodes in the neck may interfere with cerebrospinal fluid (CSF) drainage from the brain, contributing to cognitive impairment, according to new multicenter research led by Weill Cornell Medicine scientists.

29 Sep 2026

Late diagnosis and systemic gaps drive high cancer death rates in the Balkans

In the Balkans, cancer survival rates lag due to late diagnoses and weak screening programs, highlighting the need for improved early detection strategies.

From BGI Genomics 29 Sep 2026

New framework maps the complex link between psychological status and cardiovascular health

CVD remains the leading cause of death worldwide, while the global burden of mental disorders continues to rise.

28 Sep 2026

Emerging therapies expand the treatment landscape for coronary artery disease

Announcing a new article publication for Cardiovascular Innovations and Applications. Coronary artery disease (CAD) remains the leading cause of death globally, despite the limited efficacy of current pharmacological therapies.

25 Sep 2026

Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research

The Aperio AI Store integrates Tempus' AI applications, transforming complex pathology images into research insights and accelerating cancer diagnostics.

From Leica Biosystems 25 Sep 2026

New multimodal AI model improves breast cancer screening accuracy

Breast cancer screening must balance diagnostic accuracy with workflow throughput. DM remains the traditional cornerstone, but its two-dimensional projection creates tissue-overlap noise, particularly in dense breasts, leading to false positives and obscured lesions.

24 Sep 2026

Precision Medicine News and Research

Beyond ‘bad’ cholesterol: new clues to the risk of heart disease

Mursla Bio publishes peer-reviewed validation of tissue-specific extracellular vesicle platform for liquid biopsy

New review highlights expanding potential of therapeutic DNA vaccines

Study identifies a link between specific brain circuits and anxiety in adolescents

DNA Typewriter tracks cell divisions and developmental decisions in mice

Precise phenotyping improves genetic prediction of sensorineural hearing loss

ELRIG and The Protein Society announce keynote speakers for Protein Sciences in Drug Discovery 2026

C-Path and University of Arizona collaborate to investigate cellular mechanisms of Parkinson's disease in women

Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer

New model predicts growth hormone therapy response in children with short stature

Varying mutation rates in healthy organs explain cancer risk

Common gene variant reduces effectiveness of pediatric asthma drug

Esophageal cancer leaves a distinct metabolic signature in the gut

Label-free microfluidic chip and AI identify blood-borne tumor cells

Neck lymph node removal surgery may disrupt brain waste clearance

Late diagnosis and systemic gaps drive high cancer death rates in the Balkans

New framework maps the complex link between psychological status and cardiovascular health

Emerging therapies expand the treatment landscape for coronary artery disease

Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research

New multimodal AI model improves breast cancer screening accuracy

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News